2014-2026 Global Cancer Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

SKU ID :Maia-14769650 | Published Date: 12-Dec-2019 | No. of pages: 111
Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Cancer Drugs Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Cancer Drugs Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Cancer Drugs Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Cancer Drugs Market-Segmentation by Type 5.1 Breast Cancer 5.2 Blood Cancer 5.3 Gastrointestinal Cancer 5.4 Prostate Cancer 5.5 Skin Cancer 5.6 Lung Cancer 6 Global Cancer Drugs Market-Segmentation by Application 6.1 Immunotherapy 6.2 Targeted Therapy 6.3 Chemotherapy 6.4 Hormone Therapy 7 Global Cancer Drugs Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Merck 8.1.1 Merck Profile 8.1.2 Merck Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Merck Product/Solution Launches and Enhancements Analysis 8.1.4 Merck Business Overview/Recent Development/Acquisitions 8.2 Bristol-Myers Squibb 8.2.1 Bristol-Myers Squibb Profile 8.2.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis 8.2.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions 8.3 Teva Pharmaceuticals 8.3.1 Teva Pharmaceuticals Profile 8.3.2 Teva Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Teva Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.3.4 Teva Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.4 Boehringer Ingelheim 8.4.1 Boehringer Ingelheim Profile 8.4.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis 8.4.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions 8.5 Celgene Corporation 8.5.1 Celgene Corporation Profile 8.5.2 Celgene Corporation Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Celgene Corporation Product/Solution Launches and Enhancements Analysis 8.5.4 Celgene Corporation Business Overview/Recent Development/Acquisitions 8.6 Ariad Pharmaceuticals 8.6.1 Ariad Pharmaceuticals Profile 8.6.2 Ariad Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Ariad Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.6.4 Ariad Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.7 Novartis 8.7.1 Novartis Profile 8.7.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Novartis Product/Solution Launches and Enhancements Analysis 8.7.4 Novartis Business Overview/Recent Development/Acquisitions 8.8 Eli Lilly 8.8.1 Eli Lilly Profile 8.8.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Eli Lilly Product/Solution Launches and Enhancements Analysis 8.8.4 Eli Lilly Business Overview/Recent Development/Acquisitions 8.9 Bayer 8.9.1 Bayer Profile 8.9.2 Bayer Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Bayer Product/Solution Launches and Enhancements Analysis 8.9.4 Bayer Business Overview/Recent Development/Acquisitions 8.10 Sanofi and Pfizer 8.10.1 Sanofi and Pfizer Profile 8.10.2 Sanofi and Pfizer Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Sanofi and Pfizer Product/Solution Launches and Enhancements Analysis 8.10.4 Sanofi and Pfizer Business Overview/Recent Development/Acquisitions 8.11 GlaxoSmithKline 8.11.1 GlaxoSmithKline Profile 8.11.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis 8.11.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions 8.12 Amgen 8.12.1 Amgen Profile 8.12.2 Amgen Sales, Growth Rate and Global Market Share from 2014-2019E 8.12.3 Amgen Product/Solution Launches and Enhancements Analysis 8.12.4 Amgen Business Overview/Recent Development/Acquisitions 8.13 Johnson and Johnson 8.13.1 Johnson and Johnson Profile 8.13.2 Johnson and Johnson Sales, Growth Rate and Global Market Share from 2014-2019E 8.13.3 Johnson and Johnson Product/Solution Launches and Enhancements Analysis 8.13.4 Johnson and Johnson Business Overview/Recent Development/Acquisitions 8.14 Hoffmann-La Roche 8.14.1 Hoffmann-La Roche Profile 8.14.2 Hoffmann-La Roche Sales, Growth Rate and Global Market Share from 2014-2019E 8.14.3 Hoffmann-La Roche Product/Solution Launches and Enhancements Analysis 8.14.4 Hoffmann-La Roche Business Overview/Recent Development/Acquisitions 9 Global Cancer Drugs Market-Segmentation by Geography 10 North America 10.1 North America Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Cancer Drugs Production Analysis from 2014-2019E 10.4 North America Cancer Drugs Consumption Analysis from 2014-2019E 10.5 North America Cancer Drugs Import and Export from 2014-2019E 10.6 North America Cancer Drugs Value, Production and Market Share by Type (2014-2019E) 10.7 North America Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Cancer Drugs by Country (United States, Canada) 10.8.1 North America Cancer Drugs Sales by Country (2014-2019E) 10.8.2 North America Cancer Drugs Consumption Value by Country (2014-2019E) 10.9 North America Cancer Drugs Market PEST Analysis 11 Europe 11.1 Europe Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Cancer Drugs Production Analysis from 2014-2019E 11.4 Europe Cancer Drugs Consumption Analysis from 2014-2019E 11.5 Europe Cancer Drugs Import and Export from 2014-2019E 11.6 Europe Cancer Drugs Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Cancer Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Cancer Drugs Sales by Country (2014-2019E) 11.8.2 Europe Cancer Drugs Consumption Value by Country (2014-2019E) 11.9 Europe Cancer Drugs Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Cancer Drugs Production Analysis from 2014-2019E 12.4 Asia-Pacific Cancer Drugs Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Cancer Drugs Import and Export from 2014-2019E 12.6 Asia-Pacific Cancer Drugs Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Cancer Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Cancer Drugs Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Cancer Drugs Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Cancer Drugs Market PEST Analysis 13 Latin America 13.1 Latin America Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Cancer Drugs Production Analysis from 2014-2019E 13.4 Latin America Cancer Drugs Consumption Analysis from 2014-2019E 13.5 Latin America Cancer Drugs Import and Export from 2014-2019E 13.6 Latin America Cancer Drugs Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Cancer Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Cancer Drugs Sales by Country (2014-2019E) 13.8.2 Latin America Cancer Drugs Consumption Value by Country (2014-2019E) 13.9 Latin America Cancer Drugs Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Cancer Drugs Production Analysis from 2014-2019E 14.4 Middle East & Africa Cancer Drugs Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Cancer Drugs Import and Export from 2014-2019E 14.6 Middle East & Africa Cancer Drugs Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Cancer Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Cancer Drugs Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Cancer Drugs Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Cancer Drugs Market PEST Analysis 15 Future Forecast of the Global Cancer Drugs Market from 2018-2026 15.1 Future Forecast of the Global Cancer Drugs Market from 2019-2026 Segment by Region 15.2 Global Cancer Drugs Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Cancer Drugs Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source
List of Tables and Figures Global Cancer Drugs Market Value ($) and Growth Rate of Cancer Drugs from 2014-2026 Global Cancer Drugs Production and Growth Rate Segment by Product Type from 2014-2026F Global Cancer Drugs Consumption and Growth Rate Segment by Application from 2014-2019E Figure Cancer Drugs Picture Table Product Specifications of Cancer Drugs Table Driving Factors for this Market Table Industry News of Cancer Drugs Market Figure Value Chain Status of Cancer Drugs Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Cancer Drugs Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Cancer Drugs Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Breast Cancer of Cancer Drugs Figure Blood Cancer of Cancer Drugs Figure Gastrointestinal Cancer of Cancer Drugs Figure Prostate Cancer of Cancer Drugs Figure Skin Cancer of Cancer Drugs Figure Lung Cancer of Cancer Drugs Table Global Cancer Drugs Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Cancer Drugs Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Immunotherapy of Cancer Drugs Figure Targeted Therapy of Cancer Drugs Figure Chemotherapy of Cancer Drugs Figure Hormone Therapy of Cancer Drugs Table Global Cancer Drugs Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Cancer Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Cancer Drugs Figure Online Channel of Cancer Drugs Table Merck Profile (Company Name, Plants Distribution, Sales Region) Figure Merck Sales and Growth Rate from 2014-2019E Figure Merck Revenue ($) and Global Market Share from 2014-2019E Table Merck Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region) Figure Bristol-Myers Squibb Sales and Growth Rate from 2014-2019E Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2014-2019E Table Bristol-Myers Squibb Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Teva Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Teva Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Teva Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Teva Pharmaceuticals Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region) Figure Boehringer Ingelheim Sales and Growth Rate from 2014-2019E Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2014-2019E Table Boehringer Ingelheim Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Celgene Corporation Profile (Company Name, Plants Distribution, Sales Region) Figure Celgene Corporation Sales and Growth Rate from 2014-2019E Figure Celgene Corporation Revenue ($) and Global Market Share from 2014-2019E Table Celgene Corporation Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Ariad Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Ariad Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Ariad Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Ariad Pharmaceuticals Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novartis Profile (Company Name, Plants Distribution, Sales Region) Figure Novartis Sales and Growth Rate from 2014-2019E Figure Novartis Revenue ($) and Global Market Share from 2014-2019E Table Novartis Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region) Figure Eli Lilly Sales and Growth Rate from 2014-2019E Figure Eli Lilly Revenue ($) and Global Market Share from 2014-2019E Table Eli Lilly Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bayer Profile (Company Name, Plants Distribution, Sales Region) Figure Bayer Sales and Growth Rate from 2014-2019E Figure Bayer Revenue ($) and Global Market Share from 2014-2019E Table Bayer Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sanofi and Pfizer Profile (Company Name, Plants Distribution, Sales Region) Figure Sanofi and Pfizer Sales and Growth Rate from 2014-2019E Figure Sanofi and Pfizer Revenue ($) and Global Market Share from 2014-2019E Table Sanofi and Pfizer Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region) Figure GlaxoSmithKline Sales and Growth Rate from 2014-2019E Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2014-2019E Table GlaxoSmithKline Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Amgen Profile (Company Name, Plants Distribution, Sales Region) Figure Amgen Sales and Growth Rate from 2014-2019E Figure Amgen Revenue ($) and Global Market Share from 2014-2019E Table Amgen Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Johnson and Johnson Profile (Company Name, Plants Distribution, Sales Region) Figure Johnson and Johnson Sales and Growth Rate from 2014-2019E Figure Johnson and Johnson Revenue ($) and Global Market Share from 2014-2019E Table Johnson and Johnson Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Hoffmann-La Roche Profile (Company Name, Plants Distribution, Sales Region) Figure Hoffmann-La Roche Sales and Growth Rate from 2014-2019E Figure Hoffmann-La Roche Revenue ($) and Global Market Share from 2014-2019E Table Hoffmann-La Roche Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Cancer Drugs Production Value ($) by Region from 2014-2019E Table Global Cancer Drugs Production Value Share by Region from 2014-2019E Table Global Cancer Drugs Production by Region from 2014-2019E Table Global Cancer Drugs Consumption Value ($) by Region from 2014-2019E Table Global Cancer Drugs Consumption by Region from 2014-2019E Table North America Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Cancer Drugs Import and Export from 2014-2019E Table North America Cancer Drugs Value ($) by Type (2014-2019E) Table North America Cancer Drugs Production by Type (2014-2019E) Table North America Cancer Drugs Consumption by Application (2014-2019E) Table North America Cancer Drugs Consumption by Country (2014-2019E) Table North America Cancer Drugs Consumption Value ($) by Country (2014-2019E) Figure North America Cancer Drugs Market PEST Analysis Table Europe Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Cancer Drugs Import and Export from 2014-2019E Table Europe Cancer Drugs Value ($) by Type (2014-2019E) Table Europe Cancer Drugs Production by Type (2014-2019E) Table Europe Cancer Drugs Consumption by Application (2014-2019E) Table Europe Cancer Drugs Consumption by Country (2014-2019E) Table Europe Cancer Drugs Consumption Value ($) by Country (2014-2019E) Figure Europe Cancer Drugs Market PEST Analysis Table Asia-Pacific Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Cancer Drugs Import and Export from 2014-2019E Table Asia-Pacific Cancer Drugs Value ($) by Type (2014-2019E) Table Asia-Pacific Cancer Drugs Production by Type (2014-2019E) Table Asia-Pacific Cancer Drugs Consumption by Application (2014-2019E) Table Asia-Pacific Cancer Drugs Consumption by Country (2014-2019E) Table Asia-Pacific Cancer Drugs Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Cancer Drugs Market PEST Analysis Table Latin America Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Cancer Drugs Import and Export from 2014-2019E Table Latin America Cancer Drugs Value ($) by Type (2014-2019E) Table Latin America Cancer Drugs Production by Type (2014-2019E) Table Latin America Cancer Drugs Consumption by Application (2014-2019E) Table Latin America Cancer Drugs Consumption by Country (2014-2019E) Table Latin America Cancer Drugs Consumption Value ($) by Country (2014-2019E) Figure Latin America Cancer Drugs Market PEST Analysis Table Middle East & Africa Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Cancer Drugs Import and Export from 2014-2019E Table Middle East & Africa Cancer Drugs Value ($) by Type (2014-2019E) Table Middle East & Africa Cancer Drugs Production by Type (2014-2019E) Table Middle East & Africa Cancer Drugs Consumption by Application (2014-2019E) Table Middle East & Africa Cancer Drugs Consumption by Country (2014-2019E) Table Middle East & Africa Cancer Drugs Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Cancer Drugs Market PEST Analysis Table Global Cancer Drugs Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Cancer Drugs Production and Growth Rate Forecast by Region (2019-2026) Table Global Cancer Drugs Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Cancer Drugs Production and Growth Rate Forecast by Type (2019-2026) Table Global Cancer Drugs Consumption and Growth Rate Forecast by Application (2019-2026)
  • PRICE
  • $3460
    $5000

Our Clients